These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4491708)

  • 1. [ rpceedomgs" Intermittent 2-phase regimen in therapy of chronic pulmonary tuberculosis].
    Zierski M
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):116-23. PubMed ID: 4491708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic pulmonary tuberculosis with rifampin and ethambutol by the continuous and intermittent methods].
    Kotowska M; Zelski S
    Gruzlica; 1974 May; 42(5):417-9. PubMed ID: 4464230
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative daily followed clinical study of treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin. Daily and intermittent method].
    Gruzlica; 1975 Dec; 43(12):1067-98. PubMed ID: 1193413
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term results in a group of patients with chronic pulmonary tuberculosis treated with a regimen of RMP and ETB 2/7].
    Aman A; Nicolau G; Nicolescu M; Pralea T; Sturdza N; Stancu I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(2):115-20. PubMed ID: 227037
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 7. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
    Zierski M
    Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of rifampin and ethambutol in the treatment of pulmonary tuberculosis].
    Gol'dshteĭn VD; Prokhorov EP
    Probl Tuberk; 1973; 51(12):36-40. PubMed ID: 4782101
    [No Abstract]   [Full Text] [Related]  

  • 10. Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis.
    Sriyabhaya N; Jittinandana A; Kecharanantana P
    J Med Assoc Thai; 1974 Nov; 57(11):551-7. PubMed ID: 4452812
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J
    Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
    [No Abstract]   [Full Text] [Related]  

  • 13. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW; Jessamine AG; Eidus L
    Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
    Zierski M; Bek E; Kucharska A; Graczyk J; Bukalska Z
    Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793
    [No Abstract]   [Full Text] [Related]  

  • 16. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 19. [Organizaton and effectiveness of controlled intermittent outpatient treatment with ethambutol and rifadin in fibro-carvernous pulmonary tuberculosis].
    Rudoi NM; Eisaev BA
    Probl Tuberk; 1975; (1):17-21. PubMed ID: 1144360
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.